The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer

Journal of Evaluation in Clinical Practice

Volumn 11, Issue 4, 2005, Pages 350-356

  Dranitsaris, George ^a   Evans, William K ^a,b   Milliken, Debbie ^c   Zanke, Brent ^b,d  

^a CANCER CARE ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Provincial Drug Reimbursement Programs   (Canada)

^d Cancer Care Ontario   (Canada)

Author keywords

Cost; Gemcitabine; Guidelines; Lung cancer; Utilization; Vinorelbine

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG COST; DRUG UTILIZATION; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; DRUG UTILIZATION; DRUGS, INVESTIGATIONAL; EVIDENCE-BASED MEDICINE; FEMALE; FINANCING, GOVERNMENT; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; ONTARIO; PRACTICE GUIDELINES; VINBLASTINE;

EID: 23044465318     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2005.00546.x     Document Type: Conference Paper

References (13)

1. Bero L.A., Grilli R., Grimshaw J.M. et al. (1998) Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. British Medical Journal 317, 465-468.
2. Berthelot J.M., Will B.P. & Evans W.K. (2000) Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer. Journal of the National Cancer Institute 92, 1321-1329.
3. Evans W.K., Kocha W., Gagliardi A. et al. (1999) The use of gemcitabine in non-small cell lung cancer. Provincial Lung Cancer Disease Site Group. Cancer Prevention & Control 3, 84-94.
4. Fossella F., Pereira J.R., von Pawel J. et al. (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: the TAX 326 study group. Journal of Clinical Oncology 19, 3210-3218.
5. Kelly K., Crowly J., Bunn P.A. et al (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer. Journal of Clinical Oncology 19, 3210-3218.
6. Kleinbaum D.G. (1994) Logistic Regression: A Self-Learning Text. Springer, New York.
7. LeChevalier T., Brisgand D., Douillard J.Y. et al. (1994) Randomized study of vinorelbine and cisplatin vs vindesine and cisplatin vs vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. Journal of Clinical Oncology 12, 360-367.
8. Oxman A.D., Thomson M.A., Davis D.A. & Haynes B. (1995) No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Canadian Medical Association Journal 153, 1423-1431.
9. Ramsey S.D., Moinpour C.M., Lovato L.C., Crowley J.J., Grevstad P., Presant C.A., Rivkin S.E., Kelly K. & Gandara D.R. (2002) Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. Journal of the National Cancer Institute 94, 291-297.
10. Rittenberg C.N., Gralla R.J., Rehmeyer T.A. et al. (1995) Assessing and managing venous irritation associated with vinorelbine tartrate. Oncology Nursing Forum 22, 707-710.
11. Schiller J.H., Harrington D.A., Belani C.P. et al. (2002) Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. New England Journal of Medicine 346, 92-98.
12. Schiller J., Tilden D., Aristides M., Lees M., Kielhorn A., Manidakis N. & Bhalla S. (2004) Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe. Lung Cancer 43, 101-112.
13. Vassilomanolakis M., Koumakis G., Barbounis V. et al. (2001) Prevention of vinorelbine phlebitis with cimetidine. Support Care Cancer 9, 108-111.